---
title: "Enveric Biosciences, Inc. (ENVB.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/ENVB.US.md"
symbol: "ENVB.US"
name: "Enveric Biosciences, Inc."
industry: "Pharmaceuticals"
---

# Enveric Biosciences, Inc. (ENVB.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [www.enveric.com](https://www.enveric.com) |

## Company Profile

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development s...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.26 | 75/256 | - | - | - |
| PB | 0.84 | 36/256 | 1.72 | 1.02 | 0.80 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-03-06T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 1 | 100% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.08 |

## References

- [Company Overview](https://longbridge.com/en/quote/ENVB.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/ENVB.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/ENVB.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.